BBHC
MRNA icon

Brown Brothers Harriman & Co’s Moderna MRNA Stock Holding History

Brown Brothers Harriman & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$604K Buy
8,626
+1,783
+26% +$92.3K ﹤0.01% 652
2026
Q1 		$348K Buy
6,843
+4,172
+156% +$195K ﹤0.01% 706
2025
Q4 		$78.8K Buy
2,671
+699
+35% +$19K ﹤0.01% 950
2025
Q3 		$50.9K Buy
1,972
+1,240
+169% +$34.6K ﹤0.01% 997
2025
Q2 		$20.2K Buy
732
+292
+66% +$7.69K ﹤0.01% 1091
2025
Q1 		$12.5K Sell
440
-69
-14% -$2.45K ﹤0.01% 1032
2024
Q4 		$21.2K Sell
509
-23
-4% -$1.1K ﹤0.01% 1012
2024
Q3 		$35.6K Sell
532
-124
-19% -$11.4K ﹤0.01% 856
2024
Q2 		$77.9K Sell
656
-52
-7% -$6.58K ﹤0.01% 695
2024
Q1 		$75.4K Buy
708
+199
+39% +$20.1K ﹤0.01% 692
2023
Q4 		$50.6K Sell
509
-410
-45% -$34.5K ﹤0.01% 730
2023
Q3 		$94.9K Sell
919
-200
-18% -$22.3K ﹤0.01% 606
2023
Q2 		$136K Sell
1,119
-506
-31% -$67.5K ﹤0.01% 540
2023
Q1 		$250K Sell
1,625
-92
-5% -$15.2K ﹤0.01% 447
2022
Q4 		$308K Sell
1,717
-94
-5% -$15.4K ﹤0.01% 385
2022
Q3 		$214K Buy
1,811
+39
+2% +$5.92K ﹤0.01% 446
2022
Q2 		$253K Buy
1,772
+65
+4% +$9.29K ﹤0.01% 424
2022
Q1 		$294K Hold
1,707
– – ﹤0.01% 429
2021
Q4 		$434 Hold
1,707
– – ﹤0.01% 356
2021
Q3 		$657 Hold
1,707
– – ﹤0.01% 286
2021
Q2 		$401 Hold
1,707
– – ﹤0.01% 343
2021
Q1 		$224 Buy
1,707
+1,307
+327% +$189K ﹤0.01% 394
2020
Q4 		$42K Hold
400
– – ﹤0.01% 690
2020
Q3 		$28K Sell
400
-1,074
-73% -$74.9K ﹤0.01% 646
2020
Q2 		$95K Buy
1,474
+1,074
+269% +$58.8K ﹤0.01% 491
2020
Q1 		$12K Buy
+400
New +$9.2K ﹤0.01% 683

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Brown Brothers Harriman & Co's MRNA Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its Moderna (MRNA) stake by 26% in Q2 2026, buying an estimated $92.3K and bringing the position to 8,626 shares worth $604K. The position accounts for ﹤0.01% of the portfolio, ranked #652.

Brown Brothers Harriman & Co first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Brown Brothers Harriman & Co held 8,626 shares of Moderna worth $604K as of Q2 2026.
  • Brown Brothers Harriman & Co bought 1,783 Moderna shares in Q2 2026, an estimated $92.3K.
  • Moderna made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #652 holding.
  • Brown Brothers Harriman & Co first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.